Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time.

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240328562554/en/

Investors:
Caroline Corner
[email protected]
415-202-5678

Media:
[email protected]

Source: Personalis, Inc.

You May Also Be Interested In

• Three Hicks Thomas Partners Recognized in New Lawdragon 500 Legal Guide
• From Chiropractor to Creative Developer: Dr. Lauren Papa DC Launches Art Deco Freak to Revolutionize Historic Homes
• 12K Members Before Launch: Why Apeing Could Be the Next Big Crypto Breakout Story Beyond SOL and HYPE